检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李振光[1] 于占彩[1] 林荣海[1] 蒋东晓[1] 于永鹏[1] 丛艳斌[1]
机构地区:[1]山东省威海市文登中心医院潍坊医学院附属文登中心医院,264400
出 处:《中国实用医刊》2013年第19期11-13,共3页Chinese Journal of Practical Medicine
摘 要:目的探讨胞二磷胆碱辅助治疗对帕金森病(PD)轻度认知功能障碍(PD—MCI)的作用,以及对PD—MCI患者血浆磷脂(PLs)含量的影响。方法收集2006年5月至2011年6月间参与帕金森病协作研究的85例PD患者的人口学资料,完成帕金森病统一评定量表第Ⅲ部分(UPDRS—Ⅲ)及蒙特利尔认知评估量表(MoCA)的评测。根据评测结果将PD—MCI分为治疗组和对照组,前者在基本药物治疗的基础上加用胞磷胆碱钠胶囊100mg,3次/d口服,分别于治疗后12个月和18个月进行MoCA评测及PLs含量测定。血浆PLs测定采用层析技术结合改良的无机磷定量方法。结果85例PD患者中41例(48.2%)存在PD—MCI。治疗后12、18个月,治疗组和对照组MoCA评分比较差异均有统计学意义(P〈0.05,P〈0.01);治疗后12、18个月治疗组血浆PLs含量较对照组显著降低(P〈0.01)。结论胞二磷胆碱辅助治疗可延缓PD—MCI患者认知功能下降速率,并能降低其血浆PLs含量,具有神经保护作用。Objective To investigate the effect of citicoline adjuvant therapy on mild cognitive impairment in Parkinson' s disease (PD) and the influence on plasma phospholipids (PLs) levels. Meth-ods Eighty-five PD patients were recruited and evaluated by Unified Parkinson' s Disease Rating collected for the general information. The patients were Scale (UPDRS) m and Montreal Cognitive Assessment (MoCA). According to MoCA scores, patients with PD-MCI were divided into citicoline treatment group (citicoline 100 mg, tid orally) and control group( basic L-dopa or dopamine agonist). Reevaluating cog- nitive function by MoCA and plasma phopholipids levels at posttreatment 12 months and 18 months. Plas-. ma PLs was assayed by measuring its inorganic phosphorus after separation by chromatograph. Results Forty-one cases in 85 PD patients(48.2% ) were combined with PD-MCI. After 12 months and 18 months treatment period, MoCA scores were significantly higher in citicoline treatment group than those in control group(P 〈 0. 05, P 〈 O. O1 respectively). Plasma PLs levels were treatment group than those in control group( P 〈 0. 01 ). Conclusions significantly decreased in citicoline Citicoline is effective on the adju-vant treatment of PD-MCI, and it could delay cognitive rate of decline in patients with PD. Meanwhile, Citicoline could decrease significantly plasma PLs levels in PD-MCI. Citicoline has neuroprotective effects on patients with PD-MCI.
分 类 号:R742.5[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28